TERN
Terns Pharmaceuticals, Inc. · Healthcare
CEO Amy L. Burroughs sold $681K of Terns Pharmaceuticals, Inc.
Sold$681,108
$46.71Price
14,583Shares
−5%Stake
What TERN did after the filing
- The stock from Wed, Mar 18 open, $45.72
- +15.8%
- S&P 500, same days
- +7.5%
Measured over 30 trading days, to the Apr 30 close.
Traded Mon, Mar 16. Filed Tue, Mar 17, 6:10 PM ET, after the close. Returns use the Mar 18 open and the Apr 30 close. Not investment advice.